07 Jan 2001

Neuronika® (Neuronika® Kapseln) - Deutschland

Updated: 07 Jan 2001


Angst- u. Spannungszustände, Antriebsarmut, Dysphorie, Konzentrations- u. Leistungsschwäche, protrahiertes Entziehungssyndrom nach Alkoholabusus.

Neuronika® Description, Presentation and Dosage

Neuronika® Description

Neuronika® Drug Class Description


Neuronika® Drug Description

1 Kps. enth.: (±)-5,6-Dihydro-4-methoxy-6-styryl-pyron (D,L-Kavain) 200 mg.

Neuronika® Generic Name

Neuronika® Kapseln

Neuronika® Presentation

Neuronika® Presentation


Neuronika® Manufacturer


Related Learning Zones

Anti-Infectives Knowledge Network IFI

Anti-Infectives Knowledge Network IFI

The Anti-Infectives Knowledge Network – Invasive Fungal Infections (AIKN-IFI), an initiative by Astellas Pharma EMEA, assembles the experience and expertise of a number of thought leaders in the area of anti-infectives, with a particular focus on invasive fungal infections.

This free resource is regularly updated with congress highlights, industry reports, policy changes, clinical guidelines and downloadable material from major medical events, so make sure you return often.

August 2015 MYC/15/0023/EUa



The Hypogonadism Knowledge Centre gives healthcare professionals free access to resources on the diagnosis, treatment and monitoring of patients with the condition. The regularly-updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

Neuronika® Dosage

Neuronika® Adult Dosage

Rüböl, Partiell hydrierte Pflanzenöle, Gelbes Wachs, Hydriertes Sojabohnenöl, Sojalecithin, Gelatine, Glycerol, Farbstoffe E 171, E 172.

Neuronika® Precautions, Reactions and Contraindications

Neuronika® Special Precautions

Neuronika® Adverse Reactions

Neuronika® Adverse Reactions

Gr 1 .

Related Drugs - Psychiatry/Mental Health

Back to top